Mirati Therapeutics, Inc. (MRTX) Social Stream
Mirati Therapeutics Inc (MRTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Mirati Therapeutics Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
MRTX's average price target has moved down $99.41 over the prior 15 months.
MRTX reports an average of 47.9% for its upside potential over the past 49 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MRTX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 39 weeks, MRTX's average broker recommendation rating improved by 0.69.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- MRTX has a higher average analyst price target than 1205.17% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the large market cap category, Mirati Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 1265.67% of them.
- MRTX has a greater number of analysts covering the stock than 1127.72% of Pharmaceutical Products stocks.
- In the context of stocks in the large market cap category, Mirati Therapeutics Inc's variance in analysts' estimates is lower than -730.05% of them.
In the Pharmaceutical Products industry, JAZZ, IONS, and HZNP are the three stocks most similar to Mirati Therapeutics Inc regarding the price target and analyst recommendation information presented here.
What is the outlook for MRTX? Use POWR Ratings for clearer insight into price direction.